Form D · Biotechnology
Scudo Biosciences Inc
San Diego, X1 · CIK 0002051096
Offering snapshot reported Jan 16, 2025 · SEC filing
- Reported sold
- $50K Offering amount: $500K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 15, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 16, 2025 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-535500
Simple Agreement for Future Equity
Source: Form D, filed Jan 16, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ashley Maurice Buckle | Director, Executive |
| Sheena Mc Gowan | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11002 W Ocean Air Drive #3122
San Diego, X1, 92130
San Diego, X1, 92130